Vita 34 AG
XETRA:V3V
Vita 34 AG
XETRA:V3V
Price:
4.72 EUR
Market Closed
Updated:
Jun 1, 2024
Vita 34 AG
Long-Term Debt
|
Vita 34 AG
Long-Term Debt Peer Comparison
Comparables:
F
FME
FRE
E
1846
SYAB
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vita 34 AG
XETRA:V3V
|
Long-Term Debt
€13.8m
|
CAGR 3-Years
62%
|
CAGR 5-Years
21%
|
CAGR 10-Years
28%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Long-Term Debt
€10.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Long-Term Debt
€12.7B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
0%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Long-Term Debt
HK$313.5m
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Synlab AG
XETRA:SYAB
|
Long-Term Debt
€1.4B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Long-Term Debt?
Long-Term Debt
13.8m
EUR
13.8m
EUR
Based on the financial report for Dec 31, 2023, Vita 34 AG's Long-Term Debt amounts to 13.8m EUR.
What is Vita 34 AG's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
28%
28%
Over the last year, the Long-Term Debt growth was 14%. The average annual Long-Term Debt growth rates for Vita 34 AG have been 62% over the past three years , 21% over the past five years , and 28% over the past ten years .
You don't have any saved screeners yet
